Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2017; 06(01): 019-034
DOI: 10.4103/2278-330X.202562
Letter to the Editor

Long-term survival in a case of metastatic papillary renal cell carcinoma

Abdul Monem Essam
Department of Oncology, National Oncology Centre, The Royal Hospital, Seeb
,
Ajit Venniyoor
Department of Oncology, National Oncology Centre, The Royal Hospital, Seeb
,
Suresh Nagdev
Department of Oncology, National Oncology Centre, The Royal Hospital, Seeb
,
Itrat Mehdi
Department of Oncology, National Oncology Centre, The Royal Hospital, Seeb
,
Bassim Al Bahrani
Department of Oncology, National Oncology Centre, The Royal Hospital, Seeb
› Author Affiliations Source of Support: Nill.
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
22 December 2020

© 2017. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009;27:3584-90.
  • 2 Kroeger N, Xie W, Lee JL, Bjarnason GA, Knox JJ, Mackenzie MJ, et al. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria. Cancer 2013;119:2999-3006.
  • 3 Steffens S, Janssen M, Roos FC, Becker F, Schumacher S, Seidel C, et al. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study. Eur J Cancer 2012;48:2347-52.
  • 4 Molina AM, Jia X, Feldman DR, Hsieh JJ, Ginsberg MS, Velasco S, et al. Long-term response to sunitinib therapy for metastatic renal cell carcinoma. Clin Genitourin Cancer 2013;11:297-302.
  • 5 Lin ZH, Han EM, Lee ES, Kim CW, Kim HK, Kim I, et al. A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas. Mod Pathol 2004;17:611-6.
  • 6 Kaiser J. Biomedicine. Rare cancer successes spawn 'exceptional' research efforts. Science 2013;340:263.